| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Astaxanthin | Dyslipidemia | 2 | PM | 36009012 | 📋 | The Role of Nutraceutical Supplements, Monacolin K and Astaxanthin, and Diet in Blood Cholesterol Homeostasis in Patients with Myopathy |
| Astaxanthin | Dyslipidemia | 1 | PM | 34959932 | 📋 | The Beneficial Effects of Astaxanthin on Glucose Metabolism and Modified Low-Density Lipoprotein in Healthy Volunteers and Subjects with Prediabetes |
| Astaxanthin | HDL Low | 1 | PM | 32755613 | 📋 | The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: A meta-analysis of randomized controlled trials |
| Astaxanthin | HDL Low | 2 | PM | 28539740 | 📋 | Evaluation of Antioxidant, Hypolipidemic, and Antiatherogenic Property of Lycopene and Astaxanthin in Atherosclerosis-induced Rats |
| Astaxanthin | Hypercholesterolemia | 6 | PM | 37051124 | 📋 | Effects of Astaxanthin supplementation on selected metabolic parameters, anthropometric indices, Sirtuin1 and TNF-α levels in patients with coronary artery disease: A randomized, double-blind, placebo-controlled clinical trial |
| Astaxanthin | Hypercholesterolemia | 5 | PM | 36999233 | 📋 | Astaxanthin, a Natural Antioxidant, Lowers Cholesterol and Markers of Cardiovascular Risk in Individuals with Prediabetes and Dyslipidemia |
| Astaxanthin | Hypercholesterolemia | 2 | PM | 30723735 | 📋 | Effects of a New Combination of Medical Food on Endothelial Function and Lipid Profile in Dyslipidemic Subjects: A Pilot Randomized Trial |
| Astaxanthin | Hypercholesterolemia | 7 | PM | 27998714 | 📋 | A nutraceutical approach (Armolipid Plus) to reduce total and LDL cholesterol in individuals with mild to moderate dyslipidemia: Review of the clinical evidence |
| Astaxanthin | Hypercholesterolemia | 4 | PM | 25870124 | 📋 | Effects of a new combination of nutraceuticals with Morus alba on lipid profile, insulin sensitivity and endotelial function in dyslipidemic subjects. A cross-over, randomized, double-blind trial |
| Astaxanthin | Hypercholesterolemia | 3 | PM | 25084280 | 📋 | Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial |
| Astaxanthin | Hypercholesterolemia | 8 | PM | 22113535 | 📋 | Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients |
| Astaxanthin | Hypercholesterolemia | 1 | PM | 21964877 | 📋 | Positive Effects of Astaxanthin on Lipid Profiles and Oxidative Stress in Overweight Subjects |
| Astaxanthin | Hyperlipidemia | 2 | PM | 34375188 | 📋 | Astaxanthin Attenuates Adiponectin, Calprotectin, miRNA222 and miRNA378 in Obesity induced by High-Fat Diet in Rats |
| Astaxanthin | Hyperlipidemia | 1 | PM | 32379559 | 📋 | Antiplatelet Activity of Astaxanthin in Control- And High Cholesterol-Fed Rats Mediated by Down-Regulation of P2Y 12, Inhibition of NF-κB, and Increasing Intracellular Levels of cAMP |
| Astaxanthin | Hyperlipidemia | 4 | PM | 28539740 | 📋 | Evaluation of Antioxidant, Hypolipidemic, and Antiatherogenic Property of Lycopene and Astaxanthin in Atherosclerosis-induced Rats |
| Astaxanthin | Hyperlipidemia | 3 | PM | 26611120 | 📋 | Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease |
| Astaxanthin | Hyperuricemia | 2 | PM | 34782040 | 📋 | Astaxanthin attenuated hyperuricemia and kidney inflammation by inhibiting uric acid synthesis and the NF-κ B/NLRP3 signaling pathways in potassium oxonate and hypoxanthine-induced hyperuricemia mice |
| Astaxanthin | Hyperuricemia | 1 | PM | 33271765 | 📋 | Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine Oxidase, Adenosine Deaminase and Urate Transporters in Rats |
| Astaxanthin | Platelet Aggregation | 1 | PM | 32379559 | 📋 | Antiplatelet Activity of Astaxanthin in Control- And High Cholesterol-Fed Rats Mediated by Down-Regulation of P2Y 12, Inhibition of NF-κB, and Increasing Intracellular Levels of cAMP |
| Astaxanthin | Platelet Aggregation | 2 | PM | 27951728 | 📋 | Effects of astaxanthin on blood coagulation, fibrinolysis and platelet aggregation in hyperlipidemic rats |
